Abstract A 6 month old child presenting with seizures was found to be hypoglycaemic secondary to hyperinsulinism. A family history of type II diabetes prompted estimation of sulphonylurea in the baby's blood, which was found to be high. A multidisciplinary case conference concluded that the sulphonylurea ingestion was likely to be the result of Munchausen syndrome by proxy. When investigating hypoglycaemia of infancy this possibility should be considered. (Arch Dis Child 2000;82:392-393) 
from the second admission and were detected at a level of 806 µg/l. The assay was unable to identify the precise type of sulphonylurea. Unfortunately lack of stored blood from the first admission precluded a retrospective assay.
A multidisciplinary case conference attended by representatives from social services, police, and health workers (community paediatrician and health visitors) revealed complex problems in coping mechanisms, as well as a history of violence, and physical and sexual abuse, in several family members. It was disclosed that the mother's first child had been removed from her care, aged 3, owing to emotional, physical, and sexual abuse. Both the mother and her then partner were named as perpetrators. The case conference convened on the present occasion recommended foster care pending further police investigation of presumed Munchausen syndrome by proxy.
Discussion
The diVerential diagnosis in cases of infant hypoglycaemia includes endocrine deficiencies, inborn errors of metabolism, and hyperinsulinism. However, sulphonylurea ingestion is not commonly considered. Accidental sulphonylurea ingestion is seen in young children, 1 and cases of factitious hypoglycaemia have been reported, following intentional sulphonylurea ingestion by adults.
2 However, deliberate administration of oral hypoglycaemic agents has not previously been described in infancy. The sulphonylurea level of 806 µg/l is extremely high; the usual therapeutic range in adults is 5-200 µg/l.
There have been cases of prolonged neurological sequelae after sulphonylurea ingestion, 3 despite correction of the blood glucose, with hemiparesis, agitation, and confusion persisting for up to 48 hours post ingestion. This raises the possibility that the patient's first admission might also have been owing to sulphonylurea ingestion. Her blood glucose on admission was normal but her neurological status remained depressed for several hours.
The standard investigations for hypoglycaemia in infancy do not include an estimation of sulphonylurea concentrations. The initial finding in this child appeared consistent with endogenous hyperinsulinaemia. When investigating hypoglycaemia of infancy we suggest that a history of potentially available sources of oral hypoglycaemic agents should be elicited from carers. If such a history is obtained, estimation of sulphonylurea concentrations should be undertaken. 
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